Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Michaux

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Toxics|June 25, 2025
Nephrotoxicity and Modern Volatile Anesthetics: A Narrative ReviewBenedicte Hauquiert, Aurelien Gonze, Thibault Gennart, et al.
Annals of Translational Medicine|November 16, 2023
Mortality reduction in severe community-acquired pneumonia: key findings from a large randomized controlled trial and their clinical implicationsOvidiu Vornicu, Emily Perriens, Sydney Blackman, et al.
Diagnostics (Basel, Switzerland)|May 11, 2024
Emerging Trends in Left Ventricular Thrombus: A Comprehensive Review of Non-Ischemic and Ischemic Cardiopathies, Including Eosinophilic Myocarditis, Chagas Cardiomyopathy, Amyloidosis, and Innovative Anticoagulant ApproachesBenjamin Colle, Fabian Demeure, Julien Higny, et al.
Journal of Intensive Medicine|September 11, 2025
Carnitine deficiency in intensive care unit patients undergoing continuous renal replacement therapy-An underrecognized issue with potential for severe complicationsArnaud Robert, Julien Moury, Gauthier Nendumba, et al.
Annals of Translational Medicine|November 7, 2024
Propofol curtails survival in perioperative and critically ill patients by a relative reduction of 10%: should propofol be abandoned?Benedicte Hauquiert, Sydney Blackman, Emily Perriens, et al.
Annals of Translational Medicine|November 7, 2024
Has the CONVINCE trial convinced the nephrology and dialysis community?Julien Moury, Gauthier Nendumba, Arnaud Robert, et al.
Annals of Translational Medicine|November 7, 2024
Exploring volanesorsen: a promising approach to preventing acute pancreatitis in severe hypertriglyceridemiaJulien Moury, Gauthier Nendumba, Arnaud Robert, et al.
Annals of Translational Medicine|November 7, 2024
Optimizing endovascular thrombectomy timing and thrombolysis use for ischemic stroke: insights from the SELECT2 and TIMELESS trialsGauthier Nendumba, Julien Moury, Michael Van Nieuwenhove, et al.
Annals of Intensive Care|October 21, 2024
Immunological sub-phenotypes and response to convalescent plasma in COVID-19 induced ARDS: a secondary analysis of the CONFIDENT trialBenoît Misset, Anh Nguyet Diep, Axelle Bertrand, et al.
Annals of Intensive Care|March 6, 2026
Health-related quality of life trajectories one year after COVID-19-induced ARDS: A secondary analysis of the CONFIDENT trialAnne-Françoise Rousseau, Nadia Dardenne, Axelle Bertrand, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Toxics|June 25, 2025
Nephrotoxicity and Modern Volatile Anesthetics: A Narrative ReviewBenedicte Hauquiert, Aurelien Gonze, Thibault Gennart, et al.
Annals of Translational Medicine|November 16, 2023
Mortality reduction in severe community-acquired pneumonia: key findings from a large randomized controlled trial and their clinical implicationsOvidiu Vornicu, Emily Perriens, Sydney Blackman, et al.
Diagnostics (Basel, Switzerland)|May 11, 2024
Emerging Trends in Left Ventricular Thrombus: A Comprehensive Review of Non-Ischemic and Ischemic Cardiopathies, Including Eosinophilic Myocarditis, Chagas Cardiomyopathy, Amyloidosis, and Innovative Anticoagulant ApproachesBenjamin Colle, Fabian Demeure, Julien Higny, et al.
Journal of Intensive Medicine|September 11, 2025
Carnitine deficiency in intensive care unit patients undergoing continuous renal replacement therapy-An underrecognized issue with potential for severe complicationsArnaud Robert, Julien Moury, Gauthier Nendumba, et al.
Annals of Translational Medicine|November 7, 2024
Propofol curtails survival in perioperative and critically ill patients by a relative reduction of 10%: should propofol be abandoned?Benedicte Hauquiert, Sydney Blackman, Emily Perriens, et al.
Annals of Translational Medicine|November 7, 2024
Has the CONVINCE trial convinced the nephrology and dialysis community?Julien Moury, Gauthier Nendumba, Arnaud Robert, et al.
Annals of Translational Medicine|November 7, 2024
Exploring volanesorsen: a promising approach to preventing acute pancreatitis in severe hypertriglyceridemiaJulien Moury, Gauthier Nendumba, Arnaud Robert, et al.
Annals of Translational Medicine|November 7, 2024
Optimizing endovascular thrombectomy timing and thrombolysis use for ischemic stroke: insights from the SELECT2 and TIMELESS trialsGauthier Nendumba, Julien Moury, Michael Van Nieuwenhove, et al.
Annals of Intensive Care|October 21, 2024
Immunological sub-phenotypes and response to convalescent plasma in COVID-19 induced ARDS: a secondary analysis of the CONFIDENT trialBenoît Misset, Anh Nguyet Diep, Axelle Bertrand, et al.
Annals of Intensive Care|March 6, 2026
Health-related quality of life trajectories one year after COVID-19-induced ARDS: A secondary analysis of the CONFIDENT trialAnne-Françoise Rousseau, Nadia Dardenne, Axelle Bertrand, et al.
Pageof 5